Browsing byAuthorThomas Broome, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
2023-07-05Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus.Lee, J; Thomas Broome, S; Jansen, MI; Mandwie, M; Logan, GJ; Marzagalli, R; Musumeci, G; Castorina, A
2021-05-25Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial CellsThomas Broome, S; Fisher, T; Faiz, A; Keay, KA; Musumeci, G; Al-Badri, G; Castorina, A
2020-12Dopamine: an immune transmitter.Thomas Broome, S; Louangaphay, K; Keay, KA; Leggio, GM; Musumeci, G; Castorina, A
2022-04-26Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis.Jansen, MI; Thomas Broome, S; Castorina, A
2021-10-11PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells.Karunia, J; Niaz, A; Mandwie, M; Thomas Broome, S; Keay, KA; Waschek, JA; Al-Badri, G; Castorina, A
2022-09-28Pro-Inflammatory and Pro-Apoptotic Effects of the Non-Protein Amino Acid L-Azetidine-2-Carboxylic Acid in BV2 Microglial Cells.Piper, JA; Jansen, MI; Thomas Broome, S; Rodgers, KJ; Musumeci, G; Castorina, A
2022-12-07Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice.Thomas Broome, S; Castorina, A
2022-02-06The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson's Disease.Thomas Broome, S; Castorina, A